Healthcare
Live Price
Offline$11.13
-3.89% today
1Y Change
+315.74%
Window
Jun 23, 2025 → May 29, 2026
Coverage: 236 bars · Jun 23, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Polyrizon Ltd. (PLRZ) is a Healthcare stock with a market cap of $20.00M and listed on NASDAQ. The stock last traded around $11.13 and up 315.7% across the available one-year price window (Jun 23, 2025 → May 29, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +98.5%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +98.5%, free cash flow -295.4% with operating margin 0.0% and ROIC -17.9%. Stock Foundry combines PLRZ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PLRZ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PLRZ Max Drawdown
-72.25%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PLRZ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$711.0K
+8.7% YoY
Free Cash Flow
-$511.0K
+55.0% YoY
Revenue Growth
+0.0%
EPS Growth
+98.5%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -342K | -118K | -4K | -5K | -6K |
| Operating Income | -6M | -1M | -635K | -895K | -703K |
| EBITDA | -6M | -1M | -631K | -772K | -703K |
| Net Income | -3M | -2M | -600K | -779K | -711K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1M | 3M | 4K | 36K | 523K |
| Total Assets | 21M | 6M | 559K | 546K | 687K |
| Total Liabilities | 443K | 261K | 750K | 1M | 690K |
| Shareholder Equity | 21M | 5M | 57K | -652K | -3K |
| Total Debt | 0 | 0 | 200K | 0 | 0 |
| Net Debt | -1M | -3M | 196K | -36K | -523K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
492K
+56.5% YoY
Capital Expenditures
19K
-533.3% YoY
Free Cash Flow
511K
+55.0% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-26.1%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.